← Back to Clinical Trials
Recruiting NCT06138054

MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Schizophrenia Spectrum Disorders
Sponsor VA Office of Research and Development
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-04-01
Completion 2026-09-30
Interventions
MI-CBTechMindfulness control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to test the feasibility and acceptability of a brief behavioral intervention that combines two treatments, Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT), that have been shown to work in prior research studies. The format of the intervention will be a combination of in-person sessions and remote elements delivered via mobile phone (together called MI-CBTech). The goal of the intervention is to improve community integration in Veterans with serious mental illness (SMI) who have experienced homelessness. A time- and format-matched control arm will include remote mindfulness training. 50 Veterans with SMI experiencing homelessness will be randomized to one of the two arms (25 per arm).

Eligibility Criteria

Inclusion Criteria: * Veterans currently residing at the VA Greater Los Angeles Mental Health Residential Rehabilitation Treatment Program (Domiciliary) * age 18-65 years * diagnosis of non-affective or affective psychotic illness as confirmed by chart review * history of homelessness * sufficiently fluent in English to consent, understand procedures, and complete assessments and intervention * medically and clinically stable (i.e. able to participate in and complete assessments and intervention). Exclusion Criteria: * history of clinically significant neurological disorder determined by medical history (e.g., epilepsy) * history of serious head injury (i.e., loss of consciousness \> 1 hr, neuropsychological sequelae, cognitive rehabilitation post head injury) * evidence of IQ \< 70 or developmental disability * moderate or severe substance use disorder in the past month based on chart review

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}